Skip to main
DOCS
DOCS logo

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 17%
Buy 39%
Hold 33%
Sell 6%
Strong Sell 6%

Bulls say

Doximity Inc. has reported a substantial growth of over 100% in its point-of-care (POC) and formulary offerings during the recent buying season, indicating strong demand for its services. The company's stock has shown a positive trend, increasing by 3.2% since September 8, reflecting investor confidence in its business prospects. Moreover, the guidance for the second quarter suggests a strong likelihood of achieving targets, with potential for further upside, supported by a boost in visibility from increased upfront buying.

Bears say

Doximity is facing a challenging outlook due to uncertain economic conditions, which have prompted its pharmaceutical clients to revise their budget forecasts downward for fiscal years 2023 and 2024. Additionally, the company's shares are considered expensive when compared to its software industry peers, raising concerns about potential volatility if performance does not meet elevated investor expectations. The heightened scrutiny on financial results may lead to further disappointment if Doximity fails to deliver positive outcomes or adjust its guidance upwards.

Doximity (DOCS) has been analyzed by 18 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 39% recommend Buy, 33% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Buy based on their latest research and market trends.

According to 18 analysts, Doximity (DOCS) has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $71.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $71.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.